Back
Nektar Therapeutics Stock Predictions
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
45
NKTR
Nektar Therapeutics
Last Price:
$42.26
Seasonality Move:
6.14%
7 Day Trial
ALL ACCESS PASS
$
7
Nektar Therapeutics Stock Forecast
-
Over the next 52 weeks, Nektar Therapeutics has on average historically risen by 24.2% based on the past 31 years of stock performance.
-
Nektar Therapeutics has risen higher in 17 of those 31 years over the subsequent 52-week period, corresponding to a historical accuracy of 54.84%
-
Is Nektar Therapeutics Stock Undervalued?The current Nektar Therapeutics [NKTR] share price is $42.28. The Score for NKTR is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
-
NKTR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Nektar Therapeutics Stock Go Up Next Year?
-
Over the next 52 weeks, Nektar Therapeutics has on average historically risen by 24.2% based on the past 31 years of stock performance.
Nektar Therapeutics Stock Rating
Sell
45
Nektar Therapeutics (NKTR)
is a Sell
Is Nektar Therapeutics overpriced?
-
Nektar Therapeutics has risen higher in 17 of those 31 years over the subsequent 52-week period, corresponding to a historical accuracy of 54.84%
Nektar Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
nektar.com
52-Week Data
52-Week High:
66.92
52-Week Low:
6.48
Prediction Charts
Market Cap:
731.5M
Price in USD:
42.28
Volume:
900K
Beta:
1.26
Technical Analysis
SMA50:
55.41
SMA100:
50.31
SMA200:
32.60
52-Wk Change:
203.08%
Stock Predictions
-
Is Nektar Therapeutics stock public?Yes, Nektar Therapeutics is a publicly traded company.
-
What is the Nektar Therapeutics stock quote today?The Nektar Therapeutics stock price is 42.28 USD today.
-
How to buy Nektar Therapeutics stock online?You can buy Nektar Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Dec-11 | 57.33 | 51.12 | 57.90 | 51.04 |
| Dec-12 | 51.27 | 54.70 | 56.99 | 51.26 |
| Dec-15 | 54.01 | 53.30 | 54.20 | 52.01 |
| Dec-16 | 48.68 | 49.16 | 52.50 | 45.25 |
| Dec-17 | 50.08 | 45.43 | 51.47 | 44.34 |
| Dec-18 | 45.57 | 44.00 | 46.89 | 42.62 |
| Dec-19 | 44.10 | 46.84 | 47.12 | 43.62 |
| Dec-22 | 46.90 | 43.48 | 46.90 | 43.02 |
| Dec-23 | 43.16 | 44.46 | 44.55 | 42.95 |
| Dec-24 | 44.08 | 43.94 | 44.25 | 43.16 |
| Dec-26 | 43.61 | 44.49 | 44.91 | 43.01 |
| Dec-29 | 44.01 | 42.73 | 44.40 | 42.25 |
| Dec-30 | 42.47 | 41.90 | 42.61 | 41.32 |
| Dec-31 | 41.90 | 42.28 | 42.46 | 41.55 |
Nektar Therapeutics Earnings
Nektar Therapeutics Earnings Report: Per Share Nektar Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Nektar Therapeutics Forecast Revenue Growth
Nektar Therapeutics Stock Analysis: Historical quarterly revenues per share for Nektar Therapeutics and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.41 per share, a decrease next quarter of $0.00 per share, a decrease this year of $3.54 per share, and a decrease next year of $2.39 per share.
* Nektar Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.